Reported Earnings • Aug 10
First half 2026 earnings released: EPS: UK£0.24 (vs UK£0.20 in 1H 2025) First half 2026 results: EPS: UK£0.24 (up from UK£0.20 in 1H 2025). Revenue: UK£95.2m (up 23% from 1H 2025). Net income: UK£11.6m (up 19% from 1H 2025). Profit margin: 12% (in line with 1H 2025). Revenue is forecast to grow 7.9% p.a. on average during the next 3 years, compared to a 3.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Declared Dividend • Aug 07
First half dividend of UK£0.026 announced Shareholders will receive a dividend of UK£0.026. Ex-date: 3rd September 2026 Payment date: 5th October 2026 Dividend yield will be 1.8%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is well covered by both earnings (16% earnings payout ratio) and cash flows (26% cash payout ratio). The dividend has increased by an average of 3.4% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to decline by 1.8% over the next 3 years. However, it would need to fall by 83% to increase the payout ratio to a potentially unsustainable range. Tillkännagivande • Aug 06
Zotefoams plc Approves Interim Dividend for the Six Months Ended 30 June 2026, Payable on 5 October 2026 Zotefoams plc has approved an interim dividend of 2.63 pence per share for the six months ended 30 June 2026(HY 2025: 2.50 pence per share), an increase of 5.2%. The interim dividend will be paid on 5 October 2026 to shareholders on the Company's register at the close of business on 4 September 2026. Tillkännagivande • Jul 22
Zotefoams plc to Report First Half, 2026 Results on Aug 05, 2026 Zotefoams plc announced that they will report first half, 2026 results on Aug 05, 2026 Tillkännagivande • May 03
Zotefoams plc Confirms Final Dividend on Ordinary Share in Respect of the Year Ended 31 December 2025, Payable on 1 June 2026 Zotefoams plc confirmed that the final dividend of 5.35 pence per ordinary share in respect of the year ended 31 December 2025 will be paid on 1 June 2026 to shareholders on the register at close of business on 1 May 2026. Tillkännagivande • Apr 29
Zotefoams plc, Annual General Meeting, May 27, 2026 Zotefoams plc, Annual General Meeting, May 27, 2026. Location: 675 mitcham road, cr9 3al, croydon United Kingdom Upcoming Dividend • Apr 23
Upcoming dividend of UK£0.053 per share Eligible shareholders must have bought the stock before 30 April 2026. Payment date: 03 June 2026. Payout ratio is a comfortable 17% and this is well supported by cash flows. Trailing yield: 2.0%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (3.7%). Declared Dividend • Mar 20
Final dividend of UK£0.053 announced Shareholders will receive a dividend of UK£0.053. Ex-date: 30th April 2026 Payment date: 3rd June 2026 Dividend yield will be 2.0%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is well covered by both earnings (17% earnings payout ratio) and cash flows (18% cash payout ratio). The dividend has increased by an average of 3.4% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to decline by 2.5% over the next 3 years. However, it would need to fall by 81% to increase the payout ratio to a potentially unsustainable range. Reported Earnings • Mar 18
Full year 2025 earnings released: EPS: UK£0.46 (vs UK£0.057 loss in FY 2024) Full year 2025 results: EPS: UK£0.46 (up from UK£0.057 loss in FY 2024). Revenue: UK£158.5m (up 7.2% from FY 2024). Net income: UK£22.6m (up UK£25.4m from FY 2024). Profit margin: 14% (up from net loss in FY 2024). The move to profitability was primarily driven by lower expenses. Revenue is forecast to grow 9.9% p.a. on average during the next 3 years, compared to a 3.2% growth forecast for the Chemicals industry in Germany. Buy Or Sell Opportunity • Mar 12
Now 20% undervalued The stock has been flat over the last 90 days, currently trading at €4.30. The fair value is estimated to be €5.38, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.7% over the last 3 years. Earnings per share has declined by 46%. Revenue is forecast to grow by 28% in 2 years. Earnings are forecast to grow by 2,782% in the next 2 years. Tillkännagivande • Jan 22
Zotefoams plc Provides Unaudited Earnings Guidance for the Financial Year Ended 31 December 2025 Zotefoams plc provided unaudited earnings guidance for the financial year ended 31 December 2025. For the year, the company expects full year revenue of £158.5 million (2024: £147.8 million). This is slightly ahead of market expectations and represents strong year-on-year growth (+7.2%). Tillkännagivande • Nov 20
Zotefoams plc (LSE:ZTF) acquired Overseas Konstellation Company, S.A. for €36 million. Zotefoams plc (LSE:ZTF) acquired Overseas Konstellation Company, S.A. for €36 million on November 18, 2025. An upfront cash consideration of €27.6 million, plus a deferred element of up to €8.4 million based on Overseas Konstellation Company's financial performance in 2026. The total consideration will be funded from Zotefoams existing financial resources. Following completion of the Acquisition, OKC will continue to operate from its existing facilities in Burgos and Anglesola, Spain. The current leadership team will remain in place for at least 12 months to ensure continuity for customers, employees, and partners.
The transaction reflects TEV/EBITDA multiple of 7x. For the period ending December 31, 2024, Overseas Konstellation Company, S.A. reported EBITDA of €5.3 million and revenue of €30.1 million.
Graham Herring, Tim Metcalfe and Zach Cohen of IFC Advisory Limited acted as financial advisor for Zotefoams plc.
Zotefoams plc (LSE:ZTF) completed the acquisition of Overseas Konstellation Company, S.A. on November 18, 2025. New Risk • Nov 20
New major risk - Revenue and earnings growth Earnings have declined by 12% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings have declined by 12% per year over the past 5 years. Minor Risks Dividend is not well covered by earnings (dividend per share is over 5x earnings per share). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.5% net profit margin). Board Change • Nov 17
High number of new directors There are 6 new directors who have joined the board in the last 3 years. Independent Non-Executive Director Jack Clarke was the last director to join the board, commencing their role in 2025. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Tillkännagivande • Oct 25
Zotefoams plc Announces Board and Committee Changes Zotefoams plc announced the appointment of Jack Clarke as an independent Non-Executive Director of the Company and as a member of its Audit, Nomination and Remuneration Committees with effect from 28 October 2025. Jack brings to Zotefoams a wealth of relevant experience drawn from a long and successful executive career in senior strategy and finance roles, most recently, as CFO of Essentra plc, a FTSE global manufacturer of plastic and metal industrial components. Prior to that, he was CFO of Marshalls plc from 2014 until 2021, and between January 2010 and September 2014, he was initially the Strategy Director and then CFO of AMEC (E&I). Jack is a qualified chartered accountant and is currently a Non-Executive Director at FTSE SmallCap company, Capita plc, where he also chairs its Audit & Risk Committee. The Company also announces the retirement from the Board and its Committees of Doug Robertson on 31 December 2025. Jack will assume the role of Audit Committee Chair at this time and Non-Executive Director, Malcolm Swift, will become the Senior Independent Director alongside his existing role as Chair of the Board's Remuneration Committee. Tillkännagivande • Aug 28
Zotefoams plc Appoints Simon Comer as Its First Chief Strategy & Innovation Officer Zotefoams plc announced to strengthen leadership of innovation and strategic projects, the company has appointed Simon Comer as its first Chief Strategy & Innovation Officer, expanding on his previous role as Group Strategy & Delivery Director. In his new role, Simon will oversee the Innovation & Development team, the Results Delivery Office and corporate development, ensuring innovation is aligned with disciplined execution in support of the Group's strategic priorities. Tillkännagivande • May 22
Zotefoams plc Approves Final Dividend for Year Ended 31 December 2024, Payable on 2 June, 2025 Zotefoams plc announced that at its Annual General Meeting held on 22 May 2025, the company approved to declare a final dividend for the year ended 31 December 2024 of 5.10 pence per ordinary share, such dividend to be payable on 2 June 2025 to shareholders on the register of members of the Company at the close of business on 2 May 2025. Tillkännagivande • Apr 22
Zotefoams plc, Annual General Meeting, May 22, 2025 Zotefoams plc, Annual General Meeting, May 22, 2025. Location: the registered office of the company, 675 mitcham road, cr9 3al, croydon United Kingdom Tillkännagivande • Mar 03
Zotefoams plc Announces Retirement of Gary McGrathas Group CFO Zotefoams plc announced that, Gary McGrath, Group CFO, will retire from his role during 2025. A search process for Gary's successor is underway and the Board will provide an update once this has concluded. Gary will remain in his existing role until 31st October 2025, or longer if required, as part of a managed succession process. Tillkännagivande • Nov 04
Zotefoams plc Provides Earnings Guidance for the Full Year 2024 Zotefoams plc provided earnings guidance for the full year 2024. With the exception of T-FIT, which is generally heavily weighted to fourth quarter, the Group has good visibility of confirmed orders across most business units for the remainder of the year. As a consequence, and while the company is remain mindful of the risk of some continued demand volatility in certain sectors, the company expected to deliver significant revenue growth in 2024 over 2023. The Board is confident in the Group's ability to carry positive momentum through the remainder of the year. Based on its current sales forecasts and foreign exchange rates, and subject to there being no material disruption to the business, it expects revenue and adjusted profit before tax to be in line with current market expectations. Tillkännagivande • Aug 07
Zotefoams plc Approves Interim Dividend, Payable on 7 October 2024 Zotefoams plc announced an interim dividend of 2.38 pence per share was approved by the Board of Directors on 5 August 2024 (2023: 2.28 pence per share). It is payable on 7 October 2024 to shareholders who are on the register at 6 September 2024. Tillkännagivande • Sep 30
Zotefoams plc Announces Board Changes Zotefoams announced the appointment of Malcolm Swift as a Non-Executive Director of the Company and Chair of the Remuneration Committee with effect from 29 September 2023, following a search process led by the Chair of the Company and supported by Korn Ferry. Malcolm will also join the Audit and Nomination Committees. Malcolm is an Executive Vice President of McCormick & Co, a company listed on NYSE, from which he will retire at the end of 2023. He joined the company in 2005 and has held a series of executive positions, including President Global Flavour Solutions and Chief Administrative Officer. He is President of the European Brands Association, an organisation representing 2,500 businesses in Europe, from SMEs to multinationalsand has held Non-Executive directorships with Devro plc and Stolt Sea Farm Holdings plc. Zotefoams also announces that Dr Alison Fielding has informed the Board of her intention to step down as Non-Executive Director and Chair of the Remuneration Committee with effect from 29 September 2023 to devote more time to her other activities. Reported Earnings • Aug 09
First half 2023 earnings released: EPS: UK£0.12 (vs UK£0.094 in 1H 2022) First half 2023 results: EPS: UK£0.12 (up from UK£0.094 in 1H 2022). Revenue: UK£64.6m (up 9.5% from 1H 2022). Net income: UK£5.59m (up 22% from 1H 2022). Profit margin: 8.7% (up from 7.7% in 1H 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.2% p.a. on average during the next 3 years, compared to a 1.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Board Change • Aug 01
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 1 highly experienced director. Independent Non-Executive Chairman Lynn Drummond was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Jun 13
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 1 highly experienced director. Independent Non-Executive Chairman Lynn Drummond was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. 
